Bill Sponsor
House Amendment 85 to House Bill 4502
117th Congress(2021-2022)
Amendment sought to allow United States researchers to study and examine the potential impacts of several schedule I drugs, such as MDMA, psilocybin, and or ibogaine, that have been shown to be effective in treating critical diseases.
Active
Not Agreed to in House on Jul 27, 2021
Submitted
Jul 27, 2021
Latest Action
Jul 27, 2021
Origin Chamber
House
Type
Amendment
Amendment
A proposed change to a pending text (e.g., a bill, resolution, another amendment, or a treaty [or an associated resolution of ratification]).
Amendment Number
85
Congress
117
Sponsorship by Party
Actions (5)
07/27/2021
House amendment not agreed to: On agreeing to the Ocasio-Cortez amendment (A007) Failed by the Yeas and Nays: 140 - 285 (Roll no. 230).
07/27/2021
On agreeing to the Ocasio-Cortez amendment (A007) Failed by the Yeas and Nays: 140 - 285 (Roll no. 230).
07/27/2021
The previous question was ordered on the amendment (A007) pursuant to the rule.
07/27/2021
Amendment (A007) offered by Ms. Ocasio-Cortez. (consideration: CR H4074-4075, H4086-4087; text: CR H4074)
07/27/2021
House amendment offered
Amended Bill
Jul 29, 2021
Passed House
1
Sponsorship
Public Record
Record Updated
Feb 9, 2022 5:54:05 AM